Collectively this evidence suggests that although changes in levels of blood biomarkers may accurately reflect brain amyloid or tau burden (Table 1), this may be seen in many cognitively normal elderly individuals and unreliable in their predictive capacity for cognitive decline. Here, MAPT is linked to Mental deterioration.